These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 995035)

  • 1. [Plasma hydroxyproline in chronic renal failure (author's transl)].
    Heidbreder E; Lüke F; Heidland A
    Med Klin; 1976 Nov; 71(45):1945-51. PubMed ID: 995035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hydroxyproline content of plasma of patients with impaired renal function.
    Hart W; Duursma SA; Visser WJ; Njio LK
    Clin Nephrol; 1975; 4(3):104-8. PubMed ID: 1183097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reevaluation of the usefulness of serum free hydroxyproline as a parameter for assessing renal osteodystrophy.
    Uehara H
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):49-58. PubMed ID: 8336400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-protein-bound hydroxyproline in plasma in renal bone disease.
    Bishop MC; Smith R
    Clin Chim Acta; 1971 Jul; 33(2):403-8. PubMed ID: 5119316
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum hydroxyproline values in patients with chronic renal insufficiency (author's transl)].
    Revúsová V; Gratzlová J; Zvara V; Pribylincová V; Borosová E; Reznícek J
    Bratisl Lek Listy; 1979 Jun; 71(6):633-40. PubMed ID: 455098
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum hydroxyproline and renal osteodystrophy in patients maintained on haemodialysis.
    Goulding A; McChesney R; Irvine RO; Dixon SR
    N Z Med J; 1974 Dec; 80(530):540-4. PubMed ID: 4615274
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma hydroxyproline in renal osteodystrophy.
    Varghese Z; Moorhead JF; Tatler GL; Baillod RA; Wills MR
    Proc Eur Dial Transplant Assoc; 1973; 10(0):187-96. PubMed ID: 4802560
    [No Abstract]   [Full Text] [Related]  

  • 8. 1,25-dihydroxycholecalciferol in patients with chronic renal failure.
    Henderson RG; Ledingham JG; Norman AW; Oliver DO; Preston C; Russell RG; Small DG; Smith R; Warner GT; Woods CG
    Proc Eur Dial Transplant Assoc; 1973; 10(0):202-9. PubMed ID: 4802654
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma hydroxyproline fractions in patients with dialysis osteodystrophy.
    Varghese Z; Moorhead JF; Wills MR
    Clin Chim Acta; 1981 Feb; 110(1):105-11. PubMed ID: 7214708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone collagen metabolism in uremia--studies of plasma hydroxyproline level in chronic, non-dialyzed kidney disease].
    Heidbreder E; Lüke F; Heidland A
    Verh Dtsch Ges Inn Med; 1975; 81():971-4. PubMed ID: 1229629
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cyclic adenosine monophosphate and renal failure (author's transl)].
    Schneider W; Szántó T; Truat G
    Klin Wochenschr; 1974 Dec; 52(24):1175-6. PubMed ID: 4376190
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of biochemical with radiological findings in renal osteodystrophy.
    Moorhead JF; Varghese Z; Tatler GL; Baillod RA; Wills MR
    Ann Clin Biochem; 1975 May; 12(3):126-31. PubMed ID: 15637920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Osteodystrophy and calcinosis in chronic renal failure treated by repeated hemodialysis].
    Bagon J; Brunfaut C
    J Radiol Electrol Med Nucl; 1974 Jan; 55(1):35-9. PubMed ID: 4831994
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of treatment with dihydrotachysterol on renal function in patients with chronic renal failure.
    Cordy PE; Hodsman AB
    Miner Electrolyte Metab; 1984; 10(5):281-5. PubMed ID: 6493156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma hydroxyproline in uremia: relationships with histologic and biological indices of bone turnover.
    Cundy T; Bartlett M; Bishop M; Earnshaw M; Smith R; Kanis JA
    Metab Bone Dis Relat Res; 1983; 4(5):297-303. PubMed ID: 6621355
    [No Abstract]   [Full Text] [Related]  

  • 16. Measurement of free and total hydroxyproline by automated flow injection of serum or urine samples from maintenance hemodialysis patients with renal osteodystrophy.
    Uji Y; Karmen A; Okabe H; Hata K; Miura M; Ozaki K; Minamizaki M; Shibata T; Inayama S
    J Clin Lab Anal; 1994; 8(5):267-72. PubMed ID: 7807280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morphometric studies in early stages of renal osteopathy (author's transl)].
    Hufnagl HD; Hausen M; Traut G; Meiser RJ
    Klin Wochenschr; 1974 Nov; 52(22):1070-7. PubMed ID: 4444223
    [No Abstract]   [Full Text] [Related]  

  • 18. Urinary hydroxyproline concentration in primary hyperparathyroidism with and without renal stones.
    Sommer-Tsilenis E
    Eur Urol; 1977; 3(4):231-6. PubMed ID: 913450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen metabolism, uremia and bone.
    Avioli LV
    Kidney Int; 1973 Aug; 4(2):105-15. PubMed ID: 4598143
    [No Abstract]   [Full Text] [Related]  

  • 20. [Renal osteodystrophy in two children : a comparison of the effects of 1 alpha-hydroxycholecalciferol (author's transl)].
    Chantraine JM; Davin JC; Lambrechts L; Heynen G
    Ann Endocrinol (Paris); 1979; 40(2):161-2. PubMed ID: 475307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.